iPlan(R) RT Features the Latest in SRS Technology from BrainLAB
WESTCHESTER, Ill., Aug. 12 /CNW/ -- BrainLAB, a leader in software-driven
systems for targeted, less-invasive medical treatments, today announced that
Health Canada has approved the license for Canadian medical institutions to
use the newest version of iPlan RT Image and Dose treatment planning
software, which is currently in clinical use at select cancer centers
"The new iPlan RT offers more imaging and data integration capabilities,
dose calculation and workflows designed for surgeon participation. These
developments give our Novalis Tx(TM) Radiosurgery and ExacTrac users more
treatment flexibility and confidence. For BrainLAB, innovation is an integral
part of meeting clinicians' needs, while improving patient care," said Trevor
Earle, Product Line Director Radiotherapy/Novalis, BrainLAB.
With the release of the latest iPlan RT software in Canada, BrainLAB
extends the capabilities provided by traditional stereotactic radiosurgery
solutions to bring an enhanced level of precision to clinics nationwide. By
enhancing the user experience with enriched medical data, efficient clinical
workflows and treatment planning advances, iPlan RT has been refined to meet
the demands of all clinical parties involved in high accuracy radiation
iPlan RT Image gives clinicians tools that deliver consistency and speed
during treatment volume and organ risk definition through greater contouring
accuracy. Atlas-based segmentation uses a unique elastic fusion technique to
automatically contour important anatomical objects within two minutes for
treatment of cranial, head & neck, spine and prostate indications.
"iPlan RT's atlas-based segmentation will save our department time when
mapping critical structures, while also providing highly predictable outcomes.
Faster treatment planning and streamlined protocols will directly impact our
decision making process and the number of patients we're able to plan for with
the software," said Dr. James Robar, Associate Professor, Dalhousie University
Departments of Radiation Oncology and Physics & Atmospheric Science and
Medical Physicist at the Queen Elizabeth II Health Sciences Centre, Nova
Scotia Cancer Centre.
The advanced dose planning tools offered by iPlan RT Dose provide fast,
straightforward workflow-based setup, increasing clinical efficiency and
consistency for a diverse range of treatment modalities, including SRS, SRT,
SBRT and RT. Featuring the exclusive BrainLAB Monte Carlo Dose Calculation
Algorithm, iPlan RT Dose makes high-precision treatment available in everyday
Additionally, Dr. David Roberge, Assistant Professor of Radiation
Oncology. McGill University at Montreal General Hospital stated, "The improved
functionality of the new iPlan RT will increase our ability to use our Novalis
Tx Radiosurgery platform to treat a wide range of conditions of the brain and
body with a high level of precision. More flexibility combined with the
confidence to treat even the most complex cases will make this non-invasive
treatment option accessible for more patients."
For more information and to view online demos for iPlan RT Image and
Dose, visit www.brainlab.com.
BrainLAB develops, manufactures and markets software-driven medical
technology that enables procedures that are more precise, less invasive, and
also less expensive than traditional treatments.
Among the core products are image-guided systems that provide highly
accurate real-time information used for navigation during surgical procedures.
This utility has been further expanded to serve as a computer terminal for
physicians to more effectively access and interpret diagnostic scans and other
digital medical information for better informed decisions.
BrainLAB solutions allow expansion from a single system to operating
suites to digitally integrated hospitals covering all subspecialties from
neurosurgery, orthopedics, ENT, CMF to spine & trauma and oncology. With 3300
systems installed in over 75 countries, BrainLAB is a market leader in
The privately held BrainLAB group, founded in 1989, is headquartered in
Munich, Germany, and today employs 950 people in 16 offices across Europe,
Asia, Australia, North and South America.
For more information, visit BrainLAB at www.brainlab.com
Registered trademark of BrainLAB AG in Germany and/or the US
(TM) Novalis Tx is a trademark of Varian Medical Systems, Inc., and
For further information:
For further information: Kate Franco of BrainLAB, +1-708-486-1915,
firstname.lastname@example.org Web Site: http://www.brainlab.com